|
|
||||||||
Regular Article |
Received Aug. 30, 2004; revision received March 17, 2005; accepted May 4, 2005. From the School of Nursing, Division of Biobehavioral and Health Sciences (KBH), the Dept. of Sociology (CMJ), the Dept. of Medicine (BDJ, DJC, JHTK), the Division of Geriatrics (BDJ, DJC, JHTK), the Dept. of Biostatistics and Epidemiology (SXX), the Leonard Davis Institute of Health Economics (DJC, JHTK), the Center for Bioethics (DJC, JHTK), the Alzheimers Disease Center (SXX, JHTK), and The Institute on Aging (KBH, DJC, JHTK), at the Univ. of Pennsylvania and The Center for Health Equity Research and Promotion at the Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania (DJC). Send correspondence and reprint requests to Dr. Karen Hirschman, Institute on Aging, 3615 Chestnut Street, Philadelphia, PA 19104. e-mail: hirschk{at}nursing.upenn.edu
© 2005 American Association for Geriatric Psychiatry
Objectives: The authors examined the factors associated with 1) caregivers willingness to involve a relative with Alzheimer disease (AD) in a decision to use an AD-slowing treatment; and 2) how caregivers would resolve a disagreement over this decision with the their relative. Methods: This was a cross-sectional interview study of 102 caregivers of patients with mild-to-severestage AD, enrolled in a University Memory Disorders Clinic. Results: Forty-four percent of caregivers (45/102) said that his or her relative would participate in a decision to use an AD-slowing treatment. Logistic regression showed that having less dementia severity, being a female caregiver, and a spousal relationship were all associated with caregivers involving their relative in this decision. Among the caregivers who said they would involve their relative, the majority said they would resolve disagreements over whether to use the treatment in favor of what the patient wanted, versus what the family wanted for the patient. Male caregivers were less likely to resolve disagreements in favor of the patients preferences. Conclusion: Although most caregivers of patients in mild-to-moderate stages would include these patients in an AD treatment decision, certain caregiver characteristics, such as gender and relationship, are associated with not involving patients in this decision. Physicians working with dementia patients and their family members should take these characteristics into account when discussing treatment options and work with patientcaregiver dyads to improve the communication of preferences.
Key Words: Alzheimer Disease Family Caregivers ACE Inhibitors
This article has been cited by other articles:
![]() |
E. L. O'Neal, J. R. Adams, G. J. McHugo, A. D. Van Citters, R. E. Drake, and S. J. Bartels Preferences of Older and Younger Adults With Serious Mental Illness for Involvement in Decision-Making in Medical and Psychiatric Settings Am J Geriatr Psychiatry, October 1, 2008; 16(10): 826 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Karlawish, S. Y. H. Kim, D. Knopman, C. H. van Dyck, B. D. James, and D. Marson The Views of Alzheimer Disease Patients and Their Study Partners on Proxy Consent for Clinical Trial Enrollment Am J Geriatr Psychiatry, March 1, 2008; 16(3): 240 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hirschman, J. M. Kapo, and J. H.T. Karlawish Why Doesn't a Family Member of a Person With Advanced Dementia Use a Substituted Judgment When Making a Decision for That Person? Am J Geriatr Psychiatry, August 1, 2006; 14(8): 659 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yaffe Research and Care of Patients With Dementia: Moving Beyond Memory Loss Am J Geriatr Psychiatry, November 1, 2005; 13(11): 921 - 925. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |